This year, co-hosted with the Guangzhou Institute of Biomedicine and Health (GIBH) Chinese Academy of Sciences, Peking University, Hebei University of Technology and our Organizing Committee (OC), the 2018 Precision Medicine and Ion Channel Retreat will be held November 14th – 16th, 2018, in Guangzhou, China.
Since our inaugural meeting in 2003, the Retreat has evolved to become one of the most reputable events within the ion channel drug discovery community. For our 16th Annual Retreat, we decided to bring the meeting back to beautiful Vancouver, Canada. We gathered new speakers to discuss the latest trends in Precision Medicine, and hosted an interdisciplinary panel discussion, forging the need for collaboration within the ion channel space, and into the larger framework of Precision Medicine.
On the Ion Channel side, we incorporated new disease targets, as speakers introduced creative ways, and new techniques with the latest technology in the field. We had a parallel session as well, that included new topics of ion transporters, various channelopathies, and CiPA related cardiac toxicity.
We added new topics to the Precision Medicine section, including immunotherapy, liquid biopsies, clinical applications of NGS, and our interdisciplinary session on novel perspectives of ion channels in Precision Medicine, within the broader scope of drug discovery.
For 2018, with the expanding developments in the Asia Pacific, we are happy to bring forward new ventures for this year’s Retreat in Southern China.
We welcome your feedback, and any questions you may have. At this moment, we are receiving Abstracts, and you may contact us at the following –
For general inquiries, contact – retreat@aurorabiomed.com
Topics
Precision Medicine Session
- Novel Perspective of Ion Channels in Precision Medicine
- Molecular Diagnostic Technologies
- Cancer Diagnosis and Treatment
- Liquid Biopsy in Oncology
- Liquid Biopsy for Clinical Practice
- Immunotherapy: emerging applications and challenges
- Applications of Next Generation Sequencing
- Microarray and Biotechnology
Ion Channel Session
- Ion Channel Structure and Function
- Ion Channels as Disease Targets
- Ion Channels as Pain Targets
- Drug Development
- Screening Technologies
- Cardiac Safety and the CiPA Initiative
- Ion Transporters in Pathogenesis
- Ion Transporters in Drug Discovery
Past Attendees
- Craig January, MD, PhD – Professor at the School of Medicine and Public Health, at the University of Wisconsin
- William Catterall, PhD – Professor and Chair of University of Washington Department of Pharmacology
- Arthur Brown, PhD – CEO of MemChan; former founder & CEO of ChanTest
- Yuko Sekino, PhD – Director of Pharmacology National Institute of Health Sciences, Japan
- Edward Stevens, PhD – Head of Electrophysiology at Pfizer, Cambridge, UK
- Dennis Lo, MD, PhD – Associate Dean, Faculty of Medicine at CUHK, Foreign Associate US Academy of Sciences
- George Chandy, MD, PhD – Professor at NTU SG and UC Irvine
- Kurt Stoeckli – President & CSO at Glenmark Pharmaceuticals, Switzerland
- Hailin Zhang, MD, PhD – Vice President of Hebei Medical University
- Richard Olsen, PhD – Distinguished Professor of Neuroscience at the David Geffen School of Medicine at UCLA
- Yuklam Lo – Secretariat, and Honorary Chairman, Hong Kong Biotechlogy Organization
- An Hailong – Hebei University of Technology; Professor
- Dan Minor, PhD – Professor, Biochemistry and Biophysics, Cellular and Molecular Pharmacology, University of California
- Steve Goldstein, MD, PhD – Director at the Institute of Pediatric Sciences, University of Chicago
- John Dunlop, PhD – VP, Neuroscience Research at Amgen, Professor of Neuroscience, University of St Andrews
- Laszlo Urban, MD, PhD – Executive Director at Novartis
- Jean-Pierre Valentin, PhD – Senior Director, Head of Investigative Toxicology at UCB
Ramada Plaza Shunde
2 Linshang Road, Beijiao Town, Shunde District
Foshan City, Guangdong Province, China
Tel: +86 (757) 2239 8888
http://www.ramada.com
Corporate Sponsors
Media Sponsors
Hotel Sponsor